nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—HTR3A—myenteric nerve plexus—systemic scleroderma	0.0133	0.625	CbGeAlD
Memantine—GRIN2A—tendon—systemic scleroderma	0.00144	0.0679	CbGeAlD
Memantine—SLC22A2—digestive system—systemic scleroderma	0.00117	0.0549	CbGeAlD
Memantine—HTR3A—digestive system—systemic scleroderma	0.00101	0.0473	CbGeAlD
Memantine—HTR3A—lung—systemic scleroderma	0.00084	0.0395	CbGeAlD
Memantine—CYP2A6—lung—systemic scleroderma	0.000825	0.0388	CbGeAlD
Memantine—CYP2C19—digestive system—systemic scleroderma	0.000636	0.0299	CbGeAlD
Memantine—CYP2B6—skin of body—systemic scleroderma	0.000622	0.0293	CbGeAlD
Memantine—DRD2—lung—systemic scleroderma	0.000514	0.0242	CbGeAlD
Memantine—CYP2B6—digestive system—systemic scleroderma	0.000498	0.0234	CbGeAlD
Memantine—CYP2B6—lung—systemic scleroderma	0.000416	0.0196	CbGeAlD
Memantine—Urticaria—Leflunomide—systemic scleroderma	0.000352	0.000359	CcSEcCtD
Memantine—Body temperature increased—Leflunomide—systemic scleroderma	0.00035	0.000358	CcSEcCtD
Memantine—Abdominal pain—Leflunomide—systemic scleroderma	0.00035	0.000358	CcSEcCtD
Memantine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000349	0.000357	CcSEcCtD
Memantine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000348	0.000356	CcSEcCtD
Memantine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000355	CcSEcCtD
Memantine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000355	CcSEcCtD
Memantine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000355	CcSEcCtD
Memantine—Myocardial infarction—Prednisone—systemic scleroderma	0.000347	0.000355	CcSEcCtD
Memantine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000347	0.000355	CcSEcCtD
Memantine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000347	0.000354	CcSEcCtD
Memantine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000347	0.000354	CcSEcCtD
Memantine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000345	0.000353	CcSEcCtD
Memantine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000345	0.000353	CcSEcCtD
Memantine—Insomnia—Lisinopril—systemic scleroderma	0.000344	0.000352	CcSEcCtD
Memantine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000344	0.000351	CcSEcCtD
Memantine—Paraesthesia—Lisinopril—systemic scleroderma	0.000342	0.000349	CcSEcCtD
Memantine—Vomiting—Captopril—systemic scleroderma	0.000342	0.000349	CcSEcCtD
Memantine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00034	0.000348	CcSEcCtD
Memantine—Dyspnoea—Lisinopril—systemic scleroderma	0.000339	0.000347	CcSEcCtD
Memantine—Rash—Captopril—systemic scleroderma	0.000339	0.000346	CcSEcCtD
Memantine—Dermatitis—Captopril—systemic scleroderma	0.000338	0.000346	CcSEcCtD
Memantine—Somnolence—Lisinopril—systemic scleroderma	0.000338	0.000346	CcSEcCtD
Memantine—Headache—Captopril—systemic scleroderma	0.000337	0.000344	CcSEcCtD
Memantine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000336	0.000343	CcSEcCtD
Memantine—Dyspepsia—Lisinopril—systemic scleroderma	0.000335	0.000342	CcSEcCtD
Memantine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000334	0.000341	CcSEcCtD
Memantine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000334	0.000341	CcSEcCtD
Memantine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000333	0.000341	CcSEcCtD
Memantine—Asthma—Methotrexate—systemic scleroderma	0.000332	0.000339	CcSEcCtD
Memantine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000338	CcSEcCtD
Memantine—Decreased appetite—Lisinopril—systemic scleroderma	0.000331	0.000338	CcSEcCtD
Memantine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000329	0.000336	CcSEcCtD
Memantine—Fatigue—Lisinopril—systemic scleroderma	0.000328	0.000335	CcSEcCtD
Memantine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000328	0.000335	CcSEcCtD
Memantine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000327	0.000334	CcSEcCtD
Memantine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000326	0.000334	CcSEcCtD
Memantine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000326	0.000333	CcSEcCtD
Memantine—Pancreatitis—Methotrexate—systemic scleroderma	0.000326	0.000333	CcSEcCtD
Memantine—Constipation—Lisinopril—systemic scleroderma	0.000325	0.000332	CcSEcCtD
Memantine—Pain—Lisinopril—systemic scleroderma	0.000325	0.000332	CcSEcCtD
Memantine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000332	CcSEcCtD
Memantine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000324	0.000331	CcSEcCtD
Memantine—Bradycardia—Prednisone—systemic scleroderma	0.000324	0.000331	CcSEcCtD
Memantine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000322	0.000329	CcSEcCtD
Memantine—Diarrhoea—Azathioprine—systemic scleroderma	0.000321	0.000328	CcSEcCtD
Memantine—Haemoglobin—Prednisone—systemic scleroderma	0.00032	0.000327	CcSEcCtD
Memantine—Nausea—Captopril—systemic scleroderma	0.000319	0.000326	CcSEcCtD
Memantine—Haemorrhage—Prednisone—systemic scleroderma	0.000318	0.000325	CcSEcCtD
Memantine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000318	0.000325	CcSEcCtD
Memantine—Asthenia—Leflunomide—systemic scleroderma	0.000318	0.000325	CcSEcCtD
Memantine—Hallucination—Prednisone—systemic scleroderma	0.000317	0.000323	CcSEcCtD
Memantine—Pancytopenia—Methotrexate—systemic scleroderma	0.000315	0.000322	CcSEcCtD
Memantine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000314	0.00032	CcSEcCtD
Memantine—Pruritus—Leflunomide—systemic scleroderma	0.000313	0.00032	CcSEcCtD
Memantine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000313	0.000319	CcSEcCtD
Memantine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000312	0.000318	CcSEcCtD
Memantine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000311	0.000318	CcSEcCtD
Memantine—Neutropenia—Methotrexate—systemic scleroderma	0.000311	0.000317	CcSEcCtD
Memantine—Dysuria—Methotrexate—systemic scleroderma	0.000311	0.000317	CcSEcCtD
Memantine—Dizziness—Azathioprine—systemic scleroderma	0.00031	0.000317	CcSEcCtD
Memantine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000309	0.000315	CcSEcCtD
Memantine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000306	0.000313	CcSEcCtD
Memantine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000304	0.00031	CcSEcCtD
Memantine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000303	0.00031	CcSEcCtD
Memantine—Diarrhoea—Leflunomide—systemic scleroderma	0.000303	0.00031	CcSEcCtD
Memantine—Urticaria—Lisinopril—systemic scleroderma	0.000302	0.000309	CcSEcCtD
Memantine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000308	CcSEcCtD
Memantine—Abdominal pain—Lisinopril—systemic scleroderma	0.000301	0.000307	CcSEcCtD
Memantine—Body temperature increased—Lisinopril—systemic scleroderma	0.000301	0.000307	CcSEcCtD
Memantine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000299	0.000306	CcSEcCtD
Memantine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000299	0.000305	CcSEcCtD
Memantine—Vomiting—Azathioprine—systemic scleroderma	0.000298	0.000305	CcSEcCtD
Memantine—Pneumonia—Methotrexate—systemic scleroderma	0.000298	0.000304	CcSEcCtD
Memantine—Eye disorder—Prednisone—systemic scleroderma	0.000297	0.000304	CcSEcCtD
Memantine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000297	0.000304	CcSEcCtD
Memantine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000296	0.000303	CcSEcCtD
Memantine—Infestation NOS—Methotrexate—systemic scleroderma	0.000296	0.000303	CcSEcCtD
Memantine—Infestation—Methotrexate—systemic scleroderma	0.000296	0.000303	CcSEcCtD
Memantine—Rash—Azathioprine—systemic scleroderma	0.000296	0.000302	CcSEcCtD
Memantine—Dermatitis—Azathioprine—systemic scleroderma	0.000295	0.000302	CcSEcCtD
Memantine—Depression—Methotrexate—systemic scleroderma	0.000295	0.000302	CcSEcCtD
Memantine—Flushing—Prednisone—systemic scleroderma	0.000295	0.000302	CcSEcCtD
Memantine—Headache—Azathioprine—systemic scleroderma	0.000294	0.0003	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000294	0.0003	CcSEcCtD
Memantine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000293	0.0003	CcSEcCtD
Memantine—Dizziness—Leflunomide—systemic scleroderma	0.000293	0.000299	CcSEcCtD
Memantine—Renal failure—Methotrexate—systemic scleroderma	0.000291	0.000297	CcSEcCtD
Memantine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00029	0.000296	CcSEcCtD
Memantine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000289	0.000295	CcSEcCtD
Memantine—Angiopathy—Prednisone—systemic scleroderma	0.000289	0.000295	CcSEcCtD
Memantine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000288	0.000294	CcSEcCtD
Memantine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000288	0.000294	CcSEcCtD
Memantine—Immune system disorder—Prednisone—systemic scleroderma	0.000287	0.000294	CcSEcCtD
Memantine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000285	0.000291	CcSEcCtD
Memantine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000285	0.000291	CcSEcCtD
Memantine—Arrhythmia—Prednisone—systemic scleroderma	0.000284	0.00029	CcSEcCtD
Memantine—Haematuria—Methotrexate—systemic scleroderma	0.000282	0.000288	CcSEcCtD
Memantine—Vomiting—Leflunomide—systemic scleroderma	0.000282	0.000288	CcSEcCtD
Memantine—Alopecia—Prednisone—systemic scleroderma	0.000281	0.000287	CcSEcCtD
Memantine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00028	0.000286	CcSEcCtD
Memantine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00028	0.000286	CcSEcCtD
Memantine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000279	0.000285	CcSEcCtD
Memantine—Epistaxis—Methotrexate—systemic scleroderma	0.000279	0.000285	CcSEcCtD
Memantine—Rash—Leflunomide—systemic scleroderma	0.000279	0.000285	CcSEcCtD
Memantine—Dermatitis—Leflunomide—systemic scleroderma	0.000279	0.000285	CcSEcCtD
Memantine—Mental disorder—Prednisone—systemic scleroderma	0.000279	0.000285	CcSEcCtD
Memantine—Nausea—Azathioprine—systemic scleroderma	0.000279	0.000285	CcSEcCtD
Memantine—Headache—Leflunomide—systemic scleroderma	0.000277	0.000283	CcSEcCtD
Memantine—Malnutrition—Prednisone—systemic scleroderma	0.000277	0.000283	CcSEcCtD
Memantine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000276	0.000282	CcSEcCtD
Memantine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000281	CcSEcCtD
Memantine—Asthenia—Lisinopril—systemic scleroderma	0.000273	0.000279	CcSEcCtD
Memantine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000279	CcSEcCtD
Memantine—Pruritus—Lisinopril—systemic scleroderma	0.000269	0.000275	CcSEcCtD
Memantine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000269	0.000274	CcSEcCtD
Memantine—Haemoglobin—Methotrexate—systemic scleroderma	0.000267	0.000273	CcSEcCtD
Memantine—Rash—Mycophenolic acid—systemic scleroderma	0.000266	0.000272	CcSEcCtD
Memantine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000266	0.000272	CcSEcCtD
Memantine—Hepatitis—Methotrexate—systemic scleroderma	0.000266	0.000272	CcSEcCtD
Memantine—Haemorrhage—Methotrexate—systemic scleroderma	0.000266	0.000272	CcSEcCtD
Memantine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000271	CcSEcCtD
Memantine—Headache—Mycophenolic acid—systemic scleroderma	0.000265	0.00027	CcSEcCtD
Memantine—Pharyngitis—Methotrexate—systemic scleroderma	0.000264	0.00027	CcSEcCtD
Memantine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000269	CcSEcCtD
Memantine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000269	CcSEcCtD
Memantine—Nausea—Leflunomide—systemic scleroderma	0.000263	0.000269	CcSEcCtD
Memantine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000263	0.000268	CcSEcCtD
Memantine—Vision blurred—Prednisone—systemic scleroderma	0.000261	0.000267	CcSEcCtD
Memantine—Urethral disorder—Methotrexate—systemic scleroderma	0.000261	0.000266	CcSEcCtD
Memantine—Diarrhoea—Lisinopril—systemic scleroderma	0.00026	0.000266	CcSEcCtD
Memantine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000257	0.000263	CcSEcCtD
Memantine—Visual impairment—Methotrexate—systemic scleroderma	0.000256	0.000262	CcSEcCtD
Memantine—Anaemia—Prednisone—systemic scleroderma	0.000256	0.000261	CcSEcCtD
Memantine—Agitation—Prednisone—systemic scleroderma	0.000254	0.00026	CcSEcCtD
Memantine—Dizziness—Lisinopril—systemic scleroderma	0.000252	0.000257	CcSEcCtD
Memantine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000251	0.000257	CcSEcCtD
Memantine—Nausea—Mycophenolic acid—systemic scleroderma	0.000251	0.000256	CcSEcCtD
Memantine—Malaise—Prednisone—systemic scleroderma	0.00025	0.000255	CcSEcCtD
Memantine—Vertigo—Prednisone—systemic scleroderma	0.000249	0.000254	CcSEcCtD
Memantine—Eye disorder—Methotrexate—systemic scleroderma	0.000248	0.000254	CcSEcCtD
Memantine—Syncope—Prednisone—systemic scleroderma	0.000248	0.000254	CcSEcCtD
Memantine—Tinnitus—Methotrexate—systemic scleroderma	0.000248	0.000253	CcSEcCtD
Memantine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000247	0.000252	CcSEcCtD
Memantine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000251	CcSEcCtD
Memantine—Loss of consciousness—Prednisone—systemic scleroderma	0.000243	0.000249	CcSEcCtD
Memantine—Vomiting—Lisinopril—systemic scleroderma	0.000242	0.000247	CcSEcCtD
Memantine—Angiopathy—Methotrexate—systemic scleroderma	0.000241	0.000246	CcSEcCtD
Memantine—Immune system disorder—Methotrexate—systemic scleroderma	0.00024	0.000245	CcSEcCtD
Memantine—Rash—Lisinopril—systemic scleroderma	0.00024	0.000245	CcSEcCtD
Memantine—Convulsion—Prednisone—systemic scleroderma	0.00024	0.000245	CcSEcCtD
Memantine—Dermatitis—Lisinopril—systemic scleroderma	0.00024	0.000245	CcSEcCtD
Memantine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00024	0.000245	CcSEcCtD
Memantine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000244	CcSEcCtD
Memantine—Hypertension—Prednisone—systemic scleroderma	0.000239	0.000244	CcSEcCtD
Memantine—Chills—Methotrexate—systemic scleroderma	0.000239	0.000244	CcSEcCtD
Memantine—Headache—Lisinopril—systemic scleroderma	0.000238	0.000244	CcSEcCtD
Memantine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000241	CcSEcCtD
Memantine—Arthralgia—Prednisone—systemic scleroderma	0.000236	0.000241	CcSEcCtD
Memantine—Myalgia—Prednisone—systemic scleroderma	0.000236	0.000241	CcSEcCtD
Memantine—Anxiety—Prednisone—systemic scleroderma	0.000235	0.00024	CcSEcCtD
Memantine—Alopecia—Methotrexate—systemic scleroderma	0.000235	0.00024	CcSEcCtD
Memantine—Discomfort—Prednisone—systemic scleroderma	0.000233	0.000238	CcSEcCtD
Memantine—Mental disorder—Methotrexate—systemic scleroderma	0.000233	0.000238	CcSEcCtD
Memantine—Malnutrition—Methotrexate—systemic scleroderma	0.000231	0.000236	CcSEcCtD
Memantine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000233	CcSEcCtD
Memantine—Dysgeusia—Methotrexate—systemic scleroderma	0.000227	0.000232	CcSEcCtD
Memantine—Nausea—Lisinopril—systemic scleroderma	0.000226	0.000231	CcSEcCtD
Memantine—Oedema—Prednisone—systemic scleroderma	0.000226	0.000231	CcSEcCtD
Memantine—Infection—Prednisone—systemic scleroderma	0.000225	0.000229	CcSEcCtD
Memantine—Back pain—Methotrexate—systemic scleroderma	0.000224	0.000229	CcSEcCtD
Memantine—Shock—Prednisone—systemic scleroderma	0.000222	0.000227	CcSEcCtD
Memantine—Nervous system disorder—Prednisone—systemic scleroderma	0.000222	0.000226	CcSEcCtD
Memantine—Tachycardia—Prednisone—systemic scleroderma	0.000221	0.000225	CcSEcCtD
Memantine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000225	CcSEcCtD
Memantine—Skin disorder—Prednisone—systemic scleroderma	0.00022	0.000224	CcSEcCtD
Memantine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000218	0.000223	CcSEcCtD
Memantine—Vision blurred—Methotrexate—systemic scleroderma	0.000218	0.000223	CcSEcCtD
Memantine—Anorexia—Prednisone—systemic scleroderma	0.000215	0.00022	CcSEcCtD
Memantine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000215	0.000219	CcSEcCtD
Memantine—Anaemia—Methotrexate—systemic scleroderma	0.000214	0.000219	CcSEcCtD
Memantine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000217	CcSEcCtD
Memantine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000215	CcSEcCtD
Memantine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000215	CcSEcCtD
Memantine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000213	CcSEcCtD
Memantine—Malaise—Methotrexate—systemic scleroderma	0.000209	0.000213	CcSEcCtD
Memantine—Vertigo—Methotrexate—systemic scleroderma	0.000208	0.000212	CcSEcCtD
Memantine—Leukopenia—Methotrexate—systemic scleroderma	0.000207	0.000212	CcSEcCtD
Memantine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000206	0.00021	CcSEcCtD
Memantine—Insomnia—Prednisone—systemic scleroderma	0.000204	0.000209	CcSEcCtD
Memantine—Paraesthesia—Prednisone—systemic scleroderma	0.000203	0.000207	CcSEcCtD
Memantine—Cough—Methotrexate—systemic scleroderma	0.000202	0.000206	CcSEcCtD
Memantine—Convulsion—Methotrexate—systemic scleroderma	0.000201	0.000205	CcSEcCtD
Memantine—Dyspepsia—Prednisone—systemic scleroderma	0.000199	0.000203	CcSEcCtD
Memantine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000202	CcSEcCtD
Memantine—Arthralgia—Methotrexate—systemic scleroderma	0.000197	0.000201	CcSEcCtD
Memantine—Chest pain—Methotrexate—systemic scleroderma	0.000197	0.000201	CcSEcCtD
Memantine—Myalgia—Methotrexate—systemic scleroderma	0.000197	0.000201	CcSEcCtD
Memantine—Decreased appetite—Prednisone—systemic scleroderma	0.000196	0.000201	CcSEcCtD
Memantine—Fatigue—Prednisone—systemic scleroderma	0.000195	0.000199	CcSEcCtD
Memantine—Discomfort—Methotrexate—systemic scleroderma	0.000195	0.000199	CcSEcCtD
Memantine—Constipation—Prednisone—systemic scleroderma	0.000193	0.000197	CcSEcCtD
Memantine—Confusional state—Methotrexate—systemic scleroderma	0.00019	0.000195	CcSEcCtD
Memantine—Infection—Methotrexate—systemic scleroderma	0.000188	0.000192	CcSEcCtD
Memantine—Feeling abnormal—Prednisone—systemic scleroderma	0.000186	0.00019	CcSEcCtD
Memantine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000185	0.000189	CcSEcCtD
Memantine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000185	0.000189	CcSEcCtD
Memantine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000185	0.000189	CcSEcCtD
Memantine—Skin disorder—Methotrexate—systemic scleroderma	0.000183	0.000187	CcSEcCtD
Memantine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000183	0.000187	CcSEcCtD
Memantine—Anorexia—Methotrexate—systemic scleroderma	0.00018	0.000184	CcSEcCtD
Memantine—Urticaria—Prednisone—systemic scleroderma	0.00018	0.000183	CcSEcCtD
Memantine—Abdominal pain—Prednisone—systemic scleroderma	0.000179	0.000183	CcSEcCtD
Memantine—Body temperature increased—Prednisone—systemic scleroderma	0.000179	0.000183	CcSEcCtD
Memantine—Hypotension—Methotrexate—systemic scleroderma	0.000176	0.00018	CcSEcCtD
Memantine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000172	0.000176	CcSEcCtD
Memantine—Insomnia—Methotrexate—systemic scleroderma	0.000171	0.000175	CcSEcCtD
Memantine—Paraesthesia—Methotrexate—systemic scleroderma	0.00017	0.000173	CcSEcCtD
Memantine—Dyspnoea—Methotrexate—systemic scleroderma	0.000168	0.000172	CcSEcCtD
Memantine—Somnolence—Methotrexate—systemic scleroderma	0.000168	0.000172	CcSEcCtD
Memantine—Hypersensitivity—Prednisone—systemic scleroderma	0.000167	0.00017	CcSEcCtD
Memantine—Dyspepsia—Methotrexate—systemic scleroderma	0.000166	0.00017	CcSEcCtD
Memantine—Decreased appetite—Methotrexate—systemic scleroderma	0.000164	0.000168	CcSEcCtD
Memantine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000163	0.000167	CcSEcCtD
Memantine—Fatigue—Methotrexate—systemic scleroderma	0.000163	0.000166	CcSEcCtD
Memantine—Asthenia—Prednisone—systemic scleroderma	0.000162	0.000166	CcSEcCtD
Memantine—Pain—Methotrexate—systemic scleroderma	0.000162	0.000165	CcSEcCtD
Memantine—Pruritus—Prednisone—systemic scleroderma	0.00016	0.000163	CcSEcCtD
Memantine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000156	0.000159	CcSEcCtD
Memantine—Diarrhoea—Prednisone—systemic scleroderma	0.000155	0.000158	CcSEcCtD
Memantine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000154	0.000158	CcSEcCtD
Memantine—Urticaria—Methotrexate—systemic scleroderma	0.00015	0.000153	CcSEcCtD
Memantine—Dizziness—Prednisone—systemic scleroderma	0.000149	0.000153	CcSEcCtD
Memantine—Abdominal pain—Methotrexate—systemic scleroderma	0.000149	0.000153	CcSEcCtD
Memantine—Body temperature increased—Methotrexate—systemic scleroderma	0.000149	0.000153	CcSEcCtD
Memantine—Vomiting—Prednisone—systemic scleroderma	0.000144	0.000147	CcSEcCtD
Memantine—Rash—Prednisone—systemic scleroderma	0.000142	0.000146	CcSEcCtD
Memantine—Dermatitis—Prednisone—systemic scleroderma	0.000142	0.000145	CcSEcCtD
Memantine—Headache—Prednisone—systemic scleroderma	0.000142	0.000145	CcSEcCtD
Memantine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000139	0.000142	CcSEcCtD
Memantine—Asthenia—Methotrexate—systemic scleroderma	0.000136	0.000138	CcSEcCtD
Memantine—Nausea—Prednisone—systemic scleroderma	0.000134	0.000137	CcSEcCtD
Memantine—Pruritus—Methotrexate—systemic scleroderma	0.000134	0.000137	CcSEcCtD
Memantine—Diarrhoea—Methotrexate—systemic scleroderma	0.000129	0.000132	CcSEcCtD
Memantine—Dizziness—Methotrexate—systemic scleroderma	0.000125	0.000128	CcSEcCtD
Memantine—Vomiting—Methotrexate—systemic scleroderma	0.00012	0.000123	CcSEcCtD
Memantine—Rash—Methotrexate—systemic scleroderma	0.000119	0.000122	CcSEcCtD
Memantine—Dermatitis—Methotrexate—systemic scleroderma	0.000119	0.000122	CcSEcCtD
Memantine—Headache—Methotrexate—systemic scleroderma	0.000118	0.000121	CcSEcCtD
Memantine—Nausea—Methotrexate—systemic scleroderma	0.000112	0.000115	CcSEcCtD
